Evidence map›Paper›PMID 39406710›Full record

ArticleNature communications2024

One-pot microfluidic fabrication of micro ceramic particles.

Chenchen Zhou, Shuaishuai Liang, Bin Qi, Chenxu Liu, Nam-Joon Cho

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chenchen ZhouSchool of Materials Science and Engineering, Nanyang Technological University, Singapore, 639798, Singapore.
Shuaishuai LiangSchool of Mechanical Engineering, University of Science and Technology Beijing, Beijing, 100083, P.R. China.
Bin QiSchool of Mechanical Engineering, University of Science and Technology Beijing, Beijing, 100083, P.R. China.
Chenxu LiuDepartment of Mechanical Engineering, Tsinghua University, Beijing, 100084, P.R. China.ORCID http://orcid.org/0000-0002-9057-3755
Nam-Joon ChoSchool of Materials Science and Engineering, Nanyang Technological University, Singapore, 639798, Singapore. njcho@ntu.edu.sg.ORCID http://orcid.org/0000-0002-8692-8955

Funding

National Natural Science Foundation of China (National Science Foundation of China) 51905033National Natural Science Foundation of China (National Science Foundation of China) 52105193
6 · The paper itself

Abstract

In the quest for miniaturization across technical disciplines, microscale ceramic blocks emerge as pivotal components, with performance critically dependent on precise scales and intricate shapes. Sharp-edged ceramic microparticles, applied from micromachining to microelectronics, require innovative fabrication techniques for high-throughput production while maintaining structural complexity and mechanical integrity. This study introduces a "one-pot microfluidic fabrication" system incorporating two device fabrication strategies, "groove & tongue" and sliding assembling, achieving an unprecedented array of microparticles with diverse, complex shapes and refined precision, outperforming traditional methods in production rate and quality. Optimally designed sintering profiles based on derivative thermogravimetry enhance microparticles' shape retention and structural strength. Compression and scratch tests validate the superiority of microparticles, suggesting their practicability for diverse applications, such as precise micromachining, sophisticated microrobotics and delicate microsurgical tools. This advancement marks a shift in microscale manufacturing, offering a scalable solution to meet the demanding specifications of miniaturized technology components.

Identifiers

PMID39406710
PMCPMC11480503

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.